EAC-MRH Programme Approach
Technical activities are executed by Heads of EAC Partner States National Medicines Regulatory Authority (NMRA) and eight expert working groups in charge of different regulatory functions including registration, Good Manufacturing Practices (GMP) inspections, pharmacovigilance, post marketing surveillance, clinical trials control, quality management system, medical devices and diagnostics and policy, legal and regulatory reforms.
The EAC-MRH Programme works closely with some of following key stakeholders:
- EAC Partner States’ National Medicines Regulatory Authorities;
- Pharmaceutical Industries;
- Technical Partners such as the World Health Organization (WHO), African Union Development Agency -New Partnership for Africa’s Development (AUDA-NEPAD) and Switzerland Therapeutic Agency; and
- Development Partners such as Bill and Melinda Gates Foundation (BMGF), Swiss Development Corporation (SDC), United States Agency for International Development (USAID), the World Bank, United Kingdom Department for International Development, United States Pharmacopoeia, ....